Evidence map›Paper›PMID 31264271›Full record

ArticlePhytotherapy research : PTR2019

A new insight into purinergic pharmacology: Three fungal species as natural P2X7R antagonists.

Rômulo José Soares-Bezerra, Natiele Carla da Silva Ferreira, Tânia Maria de Almeida Alves, Carlos Leomar Zani, Luiz Henrique Rosa, Robson Xavier Faria, Válber da Silva Frutuoso, Luiz Anastacio Alves

Open access · hybridAbstract read
In one paragraph

Article in Phytotherapy research : PTR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Molecules (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Rômulo José Soares-BezerraLaboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0002-8576-2869
Natiele Carla da Silva FerreiraLaboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID 0000-0003-0171-3478
Tânia Maria de Almeida AlvesLaboratory of Chemistry of Bioactive Natural Products, René Rachou Research Center, Oswaldo Cruz Foundation, Belo Horizonte, Brazil.
Carlos Leomar ZaniLaboratory of Chemistry of Bioactive Natural Products, René Rachou Research Center, Oswaldo Cruz Foundation, Belo Horizonte, Brazil.
Luiz Henrique RosaLaboratory of Polar Microbiology and Tropical Connections, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Robson Xavier FariaLaboratory of Toxoplasmosis and other Protozoosis, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Válber da Silva FrutuosoLaboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Luiz Anastacio AlvesLaboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Fundação Oswaldo Cruz · BRFaculdades Oswaldo Cruz · BRUniversidade Federal de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCell Culture TechniquesDrug DiscoveryFungiHumansMiceReceptors, Purinergic P2X7Receptors, Purinergic P2X7antagonistdrug discoveryfunginatural productsP2X7R

Identifiers

PMID31264271
PMCPMC6771832
OpenAlexW2954541948

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.